Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROMIDEPSIN for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where ROMIDEPSIN was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for ROMIDEPSIN

Side Effect Reports % Deaths Hosp.
Peripheral t-cell lymphoma unspecified 102 8.0% 73 18
Nausea 91 7.1% 11 33
Death 90 7.0% 90 10
Thrombocytopenia 90 7.0% 23 29
Pyrexia 77 6.0% 18 49
Drug ineffective 69 5.4% 19 25
Anaemia 61 4.8% 14 21
Electrocardiogram qt prolonged 61 4.8% 5 3
Platelet count decreased 60 4.7% 22 24
Vomiting 57 4.5% 5 28
Fatigue 55 4.3% 7 21
Product storage error 53 4.1% 0 0
Atrial fibrillation 52 4.1% 9 23
Neutropenia 49 3.8% 9 10
Malignant neoplasm progression 45 3.5% 17 8

Other Indications for ROMIDEPSIN

Peripheral t-cell lymphoma unspecified (390) Product used for unknown indication (171) Angioimmunoblastic t-cell lymphoma (140) Cutaneous t-cell lymphoma (101) T-cell lymphoma (81) Mycosis fungoides (48) Breast cancer metastatic (37) Lymphoma (30) Acute myeloid leukaemia (29) Adult t-cell lymphoma/leukaemia (20)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

ROMIDEPSIN Full Profile All Diffuse large b-cell lymphoma Drugs ROMIDEPSIN Demographics ROMIDEPSIN Timeline